These results were replicated in monocytes from human CGD patients, demonstrating that PPARγ activation appears to bypass the need for NADPH oxidase activation, partially restoring host defense against S. aureus in CGD [56]. This evidence concerns the gene FMO5 and chronic granulomatous disease.